HD-OPM Archive
Topics › Statins

Case report: atorvastatin caused fully reversible hearing loss in a 45-year-old woman

Louis Nervegna · Aug 27, 2026 · ♥ 3 reactions · 4 comments · original Facebook post
Statins
AI summary & key facts

Louis shares a Journal of Medical Case Reports case of atorvastatin-associated sensorineural hearing loss that resolved completely after stopping the drug. She was then switched to rosuvastatin without problems. It is a single rare case and not evidence of common risk.

A rare case of atorvastatin causing reversible hearing loss.

The hearing loss fully reversed upon stopping the atorvastatin. Afterward, the patient was switched to rosuvastatin with no problems.

Link to article:

Research Communities by Springer NatureJMCR Highlight: When a Common Cholesterol-Lowering Drug Becomes the Cause of Hearing Loss: A Reversible Case of Atorvastatin-Associated Sensorineural Hearing LossStatins are among the most frequently prescribed medications worldwide, yet auditory toxicity is rarely recognized. This JMCR case highlights reversible bilateral sensorineural hearing loss associated with atorvastatin, emphasizing the importance of early recognition and prompt drug withdrawal.communities.springernature.com

Quoted:

Atorvastatin has an established role in reducing cardiovascular morbidity and mortality and is generally considered safe. However, this case reminds clinicians that even widely prescribed medications may rarely produce unexpected neurological or otological complications.

A 45-year-old Ethiopian woman developed bilateral tinnitus followed by progressive, symmetric sensorineural hearing loss approximately three weeks after starting atorvastatin 40 mg daily. She had no history of noise exposure, chronic ear disease, head trauma, or exposure to other ototoxic medications. Audiometry confirmed bilateral moderate sensorineural hearing loss, while evaluation excluded alternative metabolic, infectious, and autoimmune causes.

The temporal relationship between drug initiation and symptom onset prompted discontinuation of atorvastatin. Improvement was already evident after one week, with complete normalization of hearing thresholds and full resolution of tinnitus by one month. Subsequent treatment with rosuvastatin was well tolerated, with no recurrence during six months of follow-up.

#atorvastatinHD #hearingHD #statinsHD #rosuvastatinHD

Research cited

Shared from BMC · original post

What happens when a common cholesterol-lowering drug becomes the cause of hearing loss?

This Behind the Paper blog post from the Journal of Medical Case Reports presents the rare case of atorvastatin-associated sensorineural hearing loss in a 45-year-old Ethiopian woman and how timely withdrawal of the suspected medication led to complete recovery.

Link in the comments.

May be an image of text
← newer: Shingrix linked to 24% lower dementia risk in over 500,000 Molder: Six converging evidence lines favor plant protein over red a →